期刊名称：NEUROCHEMICAL JOURNAL
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Neurochemical Journal (Neirokhimiya) provides a source for the communication of the latest findings in all areas of contemporary neurochemistry and other fields of relevance (including molecular biology, biochemistry, physiology, neuroimmunology, pharmacology) in an afford to expand our understanding of the functions of the nervous system. The journal presents papers on functional neurochemistry, nervous system receptors, neurotransmitters, myelin, chromaffin granules and other components of the nervous system, as well as neurophysiological and clinical aspects, behavioral reactions, etc. Relevant topics include structure and function of the nervous system proteins, neuropeptides, nucleic acids, nucleotides, lipids, and other biologically active components.
The journal is devoted to the rapid publication of regular papers containing the results of original research, reviews highlighting major developments in neurochemistry, short communications, new experimental studies that use neurochemical methodology, descriptions of new methods of value for neurochemistry, theoretical material suggesting novel principles and approaches to neurochemical problems, presentations of new hypotheses and significant findings, discussions, chronicles of congresses, meetings, and conferences with short presentations of the most sensational and timely reports, information on the activity of the Russian and International Neurochemical Societies, as well as advertisements of reagents and equipment.
Instructions to Authors
1. GENERAL INFORMATION
1.1. “Neurochemical Journal‿publishes works in all fields of neurochemistry and related areas, including biochemistry, molecular biology, bioorganic chemistry, microbiology, and medical biochemistry, which include material concerning neurochemistry.
1.2. The journal publishes original articles that contain the new results of experimental studies and methodical works that include descriptions of new methods of investigation in neurochemistry and theoretical materials with the presentation of new principles and approaches to the solution of problems of neurochemistry. The journal publishes invited reviews or those submitted by authors on timely topics of neurochemistry, short communications, discussion articles, reviews of new books, and chronicles.
Articles receiving a positive evaluation by independent reviewers are accepted for publication. The date of reception of an article is the date when the editors received the manuscript ready for publication or a revised version of the manuscript.
The journal accepts articles written in the Russian or English languages.
1.3. The manuscripts should be sent to the editorial office at: Maronovskii per. 26, room 255, Moscow, GSP-1, 119991 Russia; phone: +7 (495) 230-7967; email: neurochemistry_rus@mail333.com
All materials, including texts, figures, figure legends presented on separate pages, tables, references, and abstracts, should be presented to the editorial office in two copies. The electronic version of the manuscript also should be presented on a disk (see section “Electronic version of manuscripts‿One copy of the manuscript should be signed by each author and the head of the laboratory or the department of the institution where the work was performed.
Information on the authors, including their position, academic degree, address, phone (office and home), fax, and e-mail, as well as the corresponding author, should be presented on a separate page.
To receive confirmation of the reception of an article by the editorial office, enclosure of a postcard with a return address is recommended. Sending the manuscript using registered mail and saving a copy is also recommended
It is also necessary to enclose two Copyright Transfer Agreements.
2. STRUCTURE OF THE MANUSCRIPT
2.1. Manuscripts should be typewritten and 1.5-spaced throughout in one column without right justification on one side of a sheet of 210 × 297 mm (A4 format) white paper; the top, bottom, and left margins should be over 2.5 cm; the right margin should not be aligned. The font should be 14 point Times New Roman. All the pages of the manuscript, including tables, references, and figure legends, should be numbered; the numeration should be given at the top center.
2.2. The beginning of the manuscript should be printed using the following format: authors (initials before each last name) and the full titles of the scientific institutions (with notes showing the institution of each author and address for correspondence and requests for reprints). This is followed by the abstract (from 100 to 250 words), which should reflect the major results of the work and conclusions, and key words (to 12‿words). A footnote on the first page should contain the postal and electronic address of the corresponding author. For example:
Article Title
A. A. Ivanova*, B. B. Sidorova, and A. B. Petrovb
a Institute of Higher Nervous Activity and Neurophysiology, Russian Academy of Sciences, Moscow, Russia
b Institute of Physiology, Siberian Division, Russian Academy of Medical Sciences, Novosibirsk, Russia
Main Received
Abstract ‿B>
Key words:……‿I>
Manuscript
__________________
* Corresponding author; ul. Bulterova 5a, Moscow, 117865 Russia;
phone: +7 (495) 333-3333; email: @ (it is also possible to provide your fax number).
Use of nonstandard abbreviations and references in the abstract is not recommended.
2.3. The manuscript should be subdivided into the following parts: (1) Introduction, (2) Materials and methods, (3) Results, (4) Discussion (if the discussion is short, the “Results‿and “Discussion‿sections may be combined), (5) Conclusions, (6) Acknowledgments, and (7) References. The “Conclusions‿in the experimental works should not exceed 15 lines and should contain a short conclusion that stresses the novelty of the data in the article.
2.3.1. The “Introduction‿should contain the history of the problem with the obligatory consideration of articles in which similar studies were already performed and a statement of the goals and objectives of the study.
2.3.2. The “Materials and methods‿should contain enough information for reproduction of the study; it should also include the materials and chemicals used, along with the name of the manufacturer and their location. Well-known methods should not be described, it is possible to refer to a literature source; if a method is not widely known, it is desirable to describe the principle of the method and refer to its author. The following references are unacceptable: “catalysis was measured by method [7]" or "according to [7].‿P>
2.3.3. The “Results‿should be condensed to the utmost compatible with clarity, but should contain suf- ficient detail to understand and reproduce the work. The editors reserve the right to shorten articles independently of their volume.
The articles should contain a statistical analysis of the results. The data of a considerable number of independent experiments should be presented in a form that clearly shows their reproducibility and importance. If the goal of a study is determination of the quantitative or statistical characteristics of population the results should be presented in the following manner: (1) the number of independent experiments, (2) the mean value, (3) the standard deviation, and (4) the coefficient of variation of the standard error. It should be clearly stated whether the standard deviation or standard error was used. A convenient form for presentation of these data in a table is, for example, the following: 263 ± 2.5 (10), where the number in parentheses shows the number of values used to calculate the mean.
If the results significantly differ it is necessary to perform a test to determine significance and evaluate probability. Statistics for a normal distribution should be used unless another distribution is specified. With the utilization of other methods of statistics (for example, non-parametric ones), the results should be presented in a form corresponding to a selected method.
2.3.4. The “Discussion‿should deal with interpretation and not with recapitulation of the results; speculations not directly related to the experimental data presented should be avoided. Use of a simple and pictorial scheme to illustrate the major results is encouraged. The volume of the “Discussion‿should not exceed the volume of the “Results‿by more than a factor of 2.
If the study was supported by grants, the fund and project no. should be presented in “Acknowledgments‿after “Conclusions.‿P>
2.3.5. The list of “References‿see below for the style) should be as brief as possible but should contain all relevant recent publications of fundamental importance. The references should be cited in the text by numbers in square brackets consecutively in the order of appearance in the manuscript.
A reference should contain the surname of the authors (if the number of authors is more than four it is necessary to list three authors and add et al.), journal, year, volume, number (issue), first and last pages; or book title, city, publisher, year, and first and last pages. The style used for citation of journals, monographs, multi-author books, and theses is given in the following examples:
- Ivanov, I.M., and Petrov, P.P., Zh. Vyssh. Nerv. Deyat., 1993, vol. 43, no. 5, pp. 102�
- Gladysheva, I. P., Zamolodchikova, T. S., Sokolova, E. A., and Larionova, N. I., Biochemistry (Moscow), 1999, vol. 64, pp. 1244�.
- Rodrigues Macedo, M. L., Machado Freire, M. G., Cabrini, E. C., et al., Biochim. Biophys. Acta, 2003, vol. 1621, 170�
- Simonov, P. V., Motivated Brain, Moscow: Nauka, 1987.
- Roger, D., Self-regulation of the Brain and Behavior, Elbert, T.H., Ed., Berlin: Springer-Verlag, 1984, pp. 180�
- Gandel’man, O.A., Kinetics and Mechanism of Bioluminescent Oxidation of Fire-Fly Luciferin, Extended Abstract of Cand. Sci. (Biol.) Dissertation [in Russian], Moscow.
2.3.6. Each table should have a title and be typed on a separate sheet. The same data cannot be published in two forms, e.g., a table and a figure or a table and in the text. All table columns should have brief headings. Avoid columns with data that are easily derived from other columns, e.g., by subtraction or taking a percentage. All results of measurements should be analyzed and evaluated with the use of methods of variation statistics.
2.3.7. Figures (graphs, diagrams, etc.) should be prepared in black. All letters, numbers, and symbols should be not less than 3.3 mm and printed with an Arial font. Graph axes and curves should be appropriately labeled. Axis labels should indicate measured quantities with units. If the graph contains more than one curve, the curves should be numbered, and explanations should be provided for each number in the figure legend.
The preferred symbols for experimental points are filled and empty circles, squares, triangles, and diamonds. Individual curves may be distinguished by using solid and dotted lines. All lines should be drawn clearly and be of a width (usually 3 points) that allows for the required reduction or magnification upon final printing.
Each figure should be supplemented with an informative title and legend that make its meaning comprehensible without reference to the text. Conditions spe cific to a particular experiment should be stated. References to the text are permissible to avoid repetitions and ambiguity.
Figure legends should be grouped in the order of their appearance in the manuscript in a separate section following the list of References.
3. ELECTRONIC VERSION OF MANUSCRIPTS
The electronic version may be submitted on 3.5 inch diskettes or sent via e-mail as one text file with the entire text, including the summary, references, figure legends, tables, etc., and separate figure files.
In the electronic version, text files should be submitted in Microsoft Word 6.0 or a later version, using the Times New Roman font with a 14 point pitch.
The text format should be as simple as possible, without preprogrammed titles, insertions and cross-references, and without increased space between lines or characters. Use only the “Normal‿Word template. In particular, this refers to the “References‿section, as preprogrammed reference numbers are not recognized by the publisher?s software. The text should be in one column without division into syllables. Use of italics, bold, sub- and superscripts, Greek, and mathematical symbols should adhere to journal style.
Figures may be prepared with any editor, but the final file should be in one of the following formats: Corel Draw, MS Excel, MS Word, Power Point, jpg, tif, or bmp.
In the case of revision of article, the author should return the article within two months, otherwise, the article is considered as being newly submitted.
Failure to follow the rules of manuscript preparation may result in rejection of the manuscript.
4. MANUSCRIPT FORMAT
4.1. The International System of Physical Units (SI) is preferred.
4.2. Chemical, physical, and mathematical symbols in the text, organic compound structures, and mathematical equations should be computer-printed. Letters of similar appearance in lower and upper cases (i.e., P and p, C and c, K and k), as well as those printed in italics, should be clearly identified.
A product or quotient of two units should be written as in the example mol/sec (mol per second). In more complex groupings, the solidus should be combined with parentheses to avoid ambiguity: a/(bc) but not a/b/c or a/bc; (a/b)c but not a/b · c. Use of powers is also recommended: mol sec‿SUP>. Expressions of the type mA/gel and μmol/min · mg protein are not permitted and should be substituted by mA per gel and μmol/min per mg protein.
4.3. The recommendation of the Nomenclature Committee of the International Union of Biochemistry should be followed for abbreviations and symbols. The use of the abbreviations given below is mandatory, and they need not be defined in the text. Other abbreviations should be defined together in a footnote on the first page under the heading “Abbreviation(s).‿BR>Abbreviations are a hindrance to readers, and their use should be restricted to the minimum. Clarity and lack of ambiguity are more important than brevity. On the other hand, it is sometimes convenient to use abbreviations for the names of substances, particularly in equations, tables, and figures.
Names of complex chemical compounds should be carefully verified. It may be better to use short formulae instead of longer names, e.g., NaCl in place of sodium chloride and CH3 COOH or AcOH in place of acetic acid. When abbreviations for chemical compounds are needed, maximum use should be made of standard chemical symbols (C, H, O, P, S, Na, Cl, etc.), trivial names (e.g., folate), and symbols (e.g., Me, Pr, Ac for methyl, propyl, acetyl, respectively).
One-letter symbols are preferred over three-letter symbols for amino acid residues in polypeptides and proteins:
Alanine Ala A
Arginine Arg R
Asparagine Asn N
Aspartic acid Asp D
Aspartic acid or asparagine Asx B
Cysteine Cys C
Glutamine Gln Q
Glutamic acid Glu E
Glutamic acid or glutamine Glx Z
Glycine Gly G
Histidine His H
Isoleucine Ile I
Leucine Leu L
Lysine Lys K
Methionine Met M
Phenylalanine Phe F
Proline Pro P
Serine Ser S
Tyrosine Tyr Y
Threonine Thr T
Tryptophan Trp W
Valine Val V
The symbols for nucleosides, nucleotides, and polynucleotides are as follows:
Adenine A
Guanosine G
Inosine I
Ribosylthymine T
Uridine U
Xanthosine X
Adenosine-5'-mono-, di-, and triphosphates AMP, ADP, and ATP
Cytidine-5'-mono-, di-, and triphosphates CMP, CDP, and CTP
Guanosine-5'-mono-, di-, and triphosphates GMP, GDP, and GTP
Orotidine-5'-mono-, di-, and triphosphates OMP, ODP, and OTP
Ribothymidine-5'-mono-, di-, and triphosphates rTMP, rTDP, and rTTP
Uridine-5'-mono-, di-, and triphosphates UMP, UDP, and UTP
The corresponding deoxyribonucleotides are designated by the same symbol preceded by the lower-case letter “d,‿e.g., dATP, dGTP, etc. AMP isomers are designated as 2'-AMP, 3'-AMP, 5'-AMP, 3-:5'-AMP (adenosine- 3-:5'-monophosphate, cAMP).
Names of enzymes may be abbreviated, e.g., G6PDG (glucose-6-phosphate dehydrogenase). The abbreviation should be defined in the “Abbreviations‿paragraph on the title page. A substrate name used as part of the trivial enzyme name may be abbreviated, e.g., ATPase, Glu-decarboxylase.
The following abbreviations may be used without definition:
CNS central nervous system
ACTH adrenocorticotropic hormone
ACh acetylcholine
BSA bovine serum albumin
HPLC high performance liquid chromatography
GABA gamma-aminobutyric acid
GLC gas-liquid chromatography
BBB blood brain barrier
MAO monoamine oxidase
DEAE cellulosediethylaminoethyl cellulose
CM cellulosecarboxymethyl cellulose
PAAG polyacrylamide gel
TCA trichloroacetic acid
EDTA ethylenediaminetetraacetate
EGTA ethylene glycol-bis(β-aminoethyl ether)
N,N,N',N'-tetraacetate
CoA, CoASH coenzyme A
acyl-coAacyl derivative of coenzyme A
SDS sodium dodecyl sulfate
FAD and FADH2 flavin-adenine dinucleotide and its reduced form
FMN and FMNH2 riboflavin-5'-phosphate and its reduced form
GSH and GSSG reduced and oxidized glutathione
G-protein guanine-nucleotide-binding regulatory protein
IgGimmunoglobulin G
NAD, NAD+, and NADH nicotinamide-adenine dinucleotide and its oxidized and reduced forms
NADP, NADP+, and NADPH nicotinamide-adenine dinucleotide phosphate and its oxidized and reduced forms
PPi, inorganic phosphate
ORD, optical rotatory dispersion
CD, circular dichroism
IR and UV, infrared and ultraviolet
EPR, electron paramagnetic resonance
NMR, nuclear magnetic resonance
POPOP, 1,4-bis(5-phenyl-2-oxazolyl)benzene
PPO, 2,5-diphenyloxazol
The following symbols are used for specific preparations of nucleic acids:
Deoxyribonucleic acid, DNA
Complementary DNA, cDNA
Mitochondrial DNA, mtDNA
Ribonucleic acid, RNA
Mitochondrial RNA, mtRNA
Messenger RNA, mRNA
Ribosomal RNA, rRNA
Transfer RNA, tRNA
4.4. Nomenclature of isotopically labeled compounds.
The isotope symbol is placed in square brackets directly attached to the front of the name: [ 14C]urea, [α - 14C]leucine, L-[methyl-14C]methionine. When more than one position in a substance is labeled and the positions are not indicated, the number of labeled atoms is shown by the subscript on the right-hand side of the symbol: [ 14C2]glycolic acid. The symbol “U‿indicates uniform labeling (in [U-14C]glucose each molecule has 14C at all six positions, and the symbol “G‿indicates general labeling (in [G-14C]glucose 14C may be present at any, but not necessarily all, of the six positions). In the latter case, [14 C]glucose will suffice.
The isotope prefix precedes the part of the compound name to which it refers: iodo[ 14 C]acetic acid. When a compound contains isotopes of more than one element, their symbols are arranged alphabetically, e.g., [3- 14C, 2,3-D 15 N]serine.
Square brackets may be omitted for simple molecules by writing their chemical formulae: 14CO2, H 218O,D2O, H235SO4, 32PO43‿SUP> (but [ 32P]phosphate). The square brackets are not to be used when the isotopic symbol is attached to a word that is not a chemical name or refers to a class name of compounds: 131I-labeled, 3H-ligand, 14 C-steroids, 14 C-amino acids.
When describing experiments with labeled compounds, the absolute values of the radioactivity should be given, wherever possible, in curies (Ci), becquerels (Bq), disintegrations per minute (dpm), or counts per minute (cpm).
4.5. Recommendations on specific topics common in the biochemical literature are given below.
Animals and microorganisms. The full binomial names should be included for all experimental animals (other than common laboratory animals). The strain, the variety, and, if possible, the source of the material should be given.
Centrifugation. When the conditions for centrifugation are critical, sufficient information should be provided for the experiment to be repeated: the centrifuge rotor, the quantitative composition of the suspension medium, operation temperature, the time of rotor operation at a constant velocity (ignoring the acceleration and deceleration periods), and the centrifugal field based on the average radius of rotation of the liquid. For example: “The centrifugation was performed for 15 min at 2 ° C and 10000 g. If the periods of acceleration and deceleration are important, they should be stated.
For density-gradient centrifugation, centrifuge and rotor manufacturer(s), temperature, and gradient composition should be given. Results should preferably be presented as a function of distance from rotor center rather than as a fraction number; it is then unnecessary to indicate the top and bottom of the gradient. If fraction numbers are used, the top and bottom of the gradient should be indicated.
For ultracentrifugation, the following parameters are used: the sedimentation coefficient (not constant) s, Svedberg unit (10 ?13 s) S, partial specific volume v, and diffusion coefficient, D. The temperature at which the sedimentation and diffusion measurements were made should be given.
Chromatography. The rate of movement of a substance relative to the solvent front in paper or thin-layer chromatography is characterized by its Rf value. Solvent composition is best described in the form butanol- CH3COOH-H2 O (4 : 4 : 1 v/v).
Elution diagrams for column chromatography should be shown with the effluent volume increasing from left to right. Units of concentration and volume should be shown clearly. Column dimensions and, if possible, column void volume should also be given.
Electrophoresis. Photographs of gel electrophoregrams will be published provided that they bear important information; The composition of the electrophoretic medium, pH, temperature, electrophoretic mobilities, and operative voltage should be given. The symbol pI should be used for isoelectric point.
Enzymes. For nomenclature, the recommendations of the latest edition of Enzyme Nomenclature (1992, Academic Press, San Diego–New York) should be followed. Units of enzyme concentration should be defined in each paper in terms of the rate of the reaction catalyzed under specified conditions. The SI unit for this rate is 1 mol of substrate transformed per 1 sec (or 1 mol of product formed per 1 sec). This gives the unit of enzyme concentration called katal (symbol: kat). Units of enzyme concentration may be also expressed in terms of the amounts that catalyze other rates, e.g., 1 μmole of substrate transformed per 1 min.
Concentrations of protein solutions are often measured versus a solution of a standard protein (e.g., BSA). The standard protein used, its source, and, if possible, its water content, should be given.
The rate constants for the forward and backward reactions at the n th step of a multistep enzyme-catalyzed reaction should be represented by kn and k-n, respectively. The Michaelis constant ( Km) is defined as substrate concentration ([S]) which corresponds to v = V/2, where V (or Vmax) is the initial rate of product appearance or substrate disappearance when the enzyme is saturated with the substrate, and v is the initial rate at a given substrate concentration. For reactions involving two substrates (A and B), KAm = [A] when v = V/2 and [B] is extrapolated to infinity; the value of [A] at which v = V/2 at a finite concentration (which should be specified) of B should be referred to as the apparent Michaelis constant for A ( KAm,app). Other parameters used in enzyme kinetics include: Ks, the dissociation constant for enzyme-substrate complex; Ki, the dissociation constant for enzyme-inhibitor complex; [I]50, the inhibitor concentration at which the rate is decreased by half; h, the Hill coefficient (parameter in the Hill equation used to describe sigmoidal v versus substrate or inhibitor concentration curves) (see also “Recommendations on Symbolism and Terminology in Enzyme Kinetics‿published in Arch. Biochem. Biophys., 1983, vol. 224, pp. 732�.
The relative molecular mass (Mr , formerly “molecular weight‿is the ratio of the mass of a molecule to 1/12 of the mass of the atom 12C. Hence, it is dimensionless. The molecular mass is the mass of one molecule of a substance expressed in daltons; the dalton is defined as 1/12 of the mass of the atom 12C. Thus, a protein may be said to have a relative molecular mass of 50000 (Mr = 50000) or a molecular mass of 50000 daltons (better, 50 kD), and may be referred to as a 50 000- Mr protein or a 50-kD protein. It is not correct to express Mr in daltons. Either Mr or molecular mass (kD) should be used throughout the paper.
Solutions should be described in terms of molarity (M, mM, μM, etc.), i.e., the number of moles of substance contained in 1 liter of the solution, not normality (N). The decimal system should be used, e.g., 0.25 M HCl. The term % must be defined as w/w, w/v, or v/v, e.g., 5% (w/v) means 5 g/100 ml. For aqueous solutions of less than 1%, w/v need not be stated since it is obvious that the concentration is given in terms of the mass of solute. For solutions of salts, expressed in %, it should be made clear whether the compounds are hydrated or anhydrous.
Powers in tables and figures. Authors must exercise care in the use of powers to avoid numbers with too many digits in table headings and in figures. This is illustrated by the following example: (1) a concentration 0.00015 M may be expressed as 15 × 10‿SUP> M but it is preferable to give it by using a prefix, as 0.15 mM or 150 μM; listing of 0.15 under the heading “Concentration, mM‿or 150 under “Concentration, μM, or 15 under Concentration × 105, M‿are all appropriate. Concentrations may conveniently be indicated by square brackets.
Buffer solutions must be specified in a way that allows readers to reproduce the experimental conditions. It is useful to give the complete composition of each buffer solution in the “Materials and Methods‿section or at the first mention, e.g., 0.09 M CH3COONa/0.01 M CH3COOH, pH 5.6 (which means that the buffer solution has these concentrations of these substances).
The trivial names of the following common buffers may be used without definition:
HEPES, 4-(2-Hydroxyethyl)-1-piperazine-ethanesulfonic acid
MES, 4-Morpholine-ethanesulfonic acid
MOPS, 4-Morpholine-propanesulfonic acid
PIPES, 1,4-Piperazinediethanesulfonic acid
Tricine, N-[2-Hydroxy-1,1-bis(hydroxymethyl) ethyl]glycine
Tris, 2-Amino-2-(hydroxymethyl)-1,3-propanediol
Spectra and spectroscopic data. Full spectra should be published only if they demonstrate novel or important information. The spectra for UV or visible absorption, fluorescence, circular dichroism, and optical rotation should have a wavelength scale (nm or ?m). Wherever possible, molar terms should be used when describing absorption, optical rotation, and circular dichroism. As stated above, commonly used abbreviations of methods (ORD, CD, EPR, and NMR) need not be defined.
Visible and ultraviolet absorption spectroscopy. Symbols used include: A, absorbance; a, specific absorption coefficient (liter · g‿SUP> · cm‿SUP>) (alternatively used A1%); ?, molar absorption coefficient (absorbance of a 1 M solution in a 1 cm light-path) (liter · mol�SUP>· cm‿SUP> or M‿SUP> · cm‿SUP> but not cm2 · mol‿SUP>). No equal sign is placed between ε or A and its numerical value.
Fluorescence spectroscopy. In reporting fluorescence (F) excitation and emission spectra, it should be stated whether they are normalized or corrected, and what the nature of the correction is. Fluorescencepolarization data and spectra are reported as a polarization ratio (P) or anisotropy ratio (A); both are dimensionless.
After appearance of each issue of the journal, the publisher sends PDF-files of articles, instead of paper reprints, together with an information letter to the authors.
Instructions to Authors
guid.pdf
Editorial Board
COEDITORS-IN-CHIEF:
Armen A. Galoyan
Member of the National Academy of Sciences of the Republic of Armenia, Institute of Biochemistry National Academy of Sciences of the Republic of Armenia, Yerevan, Republic of Armenia
Natalia V. Gulyaeva
Professor, Institute of Higher Nervous Activity and Neurophysiology Russian Academy of Sciences, Moscow, Russia
EXECUTIVE EDITOR-IN-CHIEF:
Bella Ya. Gurvits
A.N. Bakh Institute of Biochemistry Russian Academy of Sciences, Moscow, Russia
EDITORIAL BOARD
M.I. Agadzhanov, N.G. Aleksidze, G.V. Aprikyan, A.V. Arutyunyan, N.F. Avrova, A.S. Bazyan, A.A. Boldyrev, A.P. Bolshakov, A.Yu. Budantsev, L.M. Gershtein, G.A. Gevorkyan, O.A. Gomazkov, E.V. Grishin, S.A. Dambinova, M.A. Davtyan, N.D. Eshchenko, K.G. Karageuzyan, E.M. Khvatova, P.G. Kostyuk, G.I. Kovalev, B.I. Kurganov, B.N. Manukhin, K.A. Markossian, D.G. Mikeladze, S.G. Morozov, M.A. Ostrovsky, L.F. Panchenko, V.O. Popov, N.K. Popova, K.S. Rayevsky, V.V. Sherstnev, E.S. Severin, V.P. Skulachev, R.M. Srapionyan, S.L. Stvolinsky, M.V. Ugryumov
INTERNATIONAL ADVISORY BOARD
A. Lajtha (Honorary Editor, USA), B.W. Agranoff (USA), A.B. Dahlstrom (Sweden), D. Dobrota (Slovakia), E. Giacobini (Switzerland), B.R. Hamprecht (Germany), C.W. Heizmann (Switzerland), L. Kaczmarek (Poland), N. Marks (USA), R. Paoletti (Italy), Ch. Richter-Landsberg (Germany), J. de Vellis (USA)
Staff Editor:
Olga N. Nikitina
|
